BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7962343)

  • 1. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
    Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
    Bertherat J; Chanson P; Dewailly D; Enjalbert A; Jaquet P; Kordon C; Peillon F; Timsit J; Epelbaum J
    Horm Res; 1992; 38(1-2):94-9. PubMed ID: 1306525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
    Reubi JC; Landolt AM
    J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
    Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
    J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
    Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
    J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
    Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
    Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
    Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic growth hormone-releasing hormone secretion by thymic carcinoid tumour.
    Boix E; Picó A; Pinedo R; Aranda I; Kovacs K
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):131-4. PubMed ID: 12100081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
    van Hoek M; Hofland LJ; de Rijke YB; van Nederveen FH; de Krijger RR; van Koetsveld PM; Lamberts SW; van der Lely AJ; de Herder WW; Feelders RA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):428-33. PubMed ID: 19017754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid.
    Zatelli MC; Maffei P; Piccin D; Martini C; Rea F; Rubello D; Margutti A; Culler MD; Sicolo N; degli Uberti EC
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2104-9. PubMed ID: 15671091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic acromegaly.
    Faglia G; Arosio M; Bazzoni N
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):575-95. PubMed ID: 1521513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly caused by growth hormone releasing hormone (GHRH) secreting tumor in multiple endocrine neoplasia (MEN-1).
    Saleem TF; Santhanam P; Hamoudeh E; Hassan T; Faiz S
    W V Med J; 2012; 108(2):26-30. PubMed ID: 22655432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.